These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3772110)
1. S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment. Gonchoroff NJ; Katzmann JA; Currie RM; Evans EL; Houck DW; Kline BC; Greipp PR; Loken MR J Immunol Methods; 1986 Oct; 93(1):97-101. PubMed ID: 3772110 [TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation. Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299 [TBL] [Abstract][Full Text] [Related]
3. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370 [TBL] [Abstract][Full Text] [Related]
4. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody. Veronese S; Gambacorta M; Falini B J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742 [TBL] [Abstract][Full Text] [Related]
6. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect. Ellwart J; Dörmer P Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309 [TBL] [Abstract][Full Text] [Related]
7. Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Dolbeare F; Beisker W; Pallavicini MG; Vanderlaan M; Gray JW Cytometry; 1985 Nov; 6(6):521-30. PubMed ID: 4064837 [TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclonal antibodies to bromodeoxyuridine. Vanderlaan M; Thomas CB Cytometry; 1985 Nov; 6(6):501-5. PubMed ID: 4064836 [TBL] [Abstract][Full Text] [Related]
9. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure. Witzig TE; Gonchoroff NJ; Greipp PR; Katzmann JA; Stenson MJ; Habermann TM; Colgan JP; Therneau TM; Banks PM Am J Clin Pathol; 1989 Mar; 91(3):298-301. PubMed ID: 2646907 [TBL] [Abstract][Full Text] [Related]
10. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ. Nagashima T; Hoshino T Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331 [TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody]. Sasaki K; Murakami T; Ogino T; Takahashi M Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667 [TBL] [Abstract][Full Text] [Related]
12. Protease antigen recovery decreases the specificity of bromodeoxyuridine detection in formalin-fixed tissue. Bak PM; Panos RJ J Histochem Cytochem; 1997 Aug; 45(8):1165-70. PubMed ID: 9267477 [TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma plasma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (BrdUrd) DNA incorporation detected by an anti-BrdUrd monoclonal antibody. Boccadoro M; Redoglio V; Gavarotti P; Pileri A Tumori; 1986 Apr; 72(2):135-7. PubMed ID: 3705185 [TBL] [Abstract][Full Text] [Related]
14. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA. Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476 [TBL] [Abstract][Full Text] [Related]
15. The use of E. coli exonuclease III to generate single stranded DNA in BrdUrd cell-cycle analysis permits simultaneous detection of cell surface antigens. Bayer JA; De Vries P; Herweijer H; Bauman JG J Immunol Methods; 1990 Aug; 132(1):13-24. PubMed ID: 2202763 [TBL] [Abstract][Full Text] [Related]
16. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram. Hoy CA; Seamer LC; Schimke RT Cytometry; 1989 Nov; 10(6):718-25. PubMed ID: 2582962 [TBL] [Abstract][Full Text] [Related]
17. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA. Miller MR; Heyneman C; Walker S; Ulrich RG J Immunol; 1986 Mar; 136(5):1791-5. PubMed ID: 3950402 [TBL] [Abstract][Full Text] [Related]
18. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Beisker W; Dolbeare F; Gray JW Cytometry; 1987 Mar; 8(2):235-9. PubMed ID: 3582069 [TBL] [Abstract][Full Text] [Related]
19. The mycoplasma-related inhibitor of HIV-1 reverse transcriptase has a DNase activity and is present in the particle-free supernatants of contaminated cultures. el-Farrash MA; Kannagi M; Kuroda MJ; Yoshida T; Harada S J Virol Methods; 1994 Apr; 47(1-2):73-82. PubMed ID: 7519627 [TBL] [Abstract][Full Text] [Related]
20. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]